Troy Wichterman Biolife Solutions Inc (BLFS) insider trading activity

BLFS Quotes by TradingView

Troy Wichterman is Chief Financial Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 122,766 shares of BLFS, which is worth approximately $3.21 Million. The most recent transaction as insider was on Nov 26, 2024, when has been sold 581 shares (Common Stock) at a price of $27.2 per share, resulting in proceeds of $15,803. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 123K
1.3% 3M change
82.31% 12M change
Total Value Held $3.21 Million

Troy Wichterman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 26 2024
SELL
Open market or private sale
$15,803 $27.2 p/Share
581 Reduced 0.47%
122,766 Common Stock
Nov 12 2024
SELL
Open market or private sale
$3,849 $26.19 p/Share
147 Reduced 0.12%
123,347 Common Stock
Oct 30 2024
SELL
Open market or private sale
$20,696 $23.15 p/Share
894 Reduced 0.72%
123,494 Common Stock
Sep 16 2024
SELL
Open market or private sale
$15,348 $25.12 p/Share
611 Reduced 0.49%
124,388 Common Stock
Aug 21 2024
SELL
Open market or private sale
$3,636 $25.61 p/Share
142 Reduced 0.11%
124,999 Common Stock
Jul 11 2024
SELL
Open market or private sale
$17,007 $20.54 p/Share
828 Reduced 0.66%
125,141 Common Stock
May 29 2024
SELL
Open market or private sale
$12,501 $21.78 p/Share
574 Reduced 0.45%
125,969 Common Stock
May 17 2024
SELL
Open market or private sale
$2,550 $22.18 p/Share
115 Reduced 0.09%
126,543 Common Stock
Apr 18 2024
SELL
Open market or private sale
$14,636 $15.31 p/Share
956 Reduced 0.75%
126,658 Common Stock
Mar 21 2024
SELL
Open market or private sale
$9,271 $17.83 p/Share
520 Reduced 0.41%
127,614 Common Stock
Mar 12 2024
SELL
Open market or private sale
$120,333 $16.6 p/Share
7,249 Reduced 5.35%
128,134 Common Stock
Mar 11 2024
SELL
Open market or private sale
$6,288 $17.42 p/Share
361 Reduced 0.27%
135,383 Common Stock
Mar 08 2024
BUY
Grant, award, or other acquisition
-
70,921 Added 34.32%
135,744 Common Stock
Feb 21 2024
SELL
Open market or private sale
$1,682 $17.35 p/Share
97 Reduced 0.15%
64,823 Common Stock
Jan 19 2024
SELL
Open market or private sale
$40,542 $16.76 p/Share
2,419 Reduced 3.59%
64,920 Common Stock
Dec 22 2023
SELL
Open market or private sale
$5,272 $16.79 p/Share
314 Reduced 0.46%
67,339 Common Stock
Dec 17 2023
BUY
Grant, award, or other acquisition
-
254 Added 0.38%
67,366 Common Stock
Dec 03 2023
BUY
Grant, award, or other acquisition
-
287 Added 0.42%
67,653 Common Stock
Dec 01 2023
SELL
Open market or private sale
$8,238 $12.37 p/Share
666 Reduced 0.98%
67,112 Common Stock
Nov 19 2023
BUY
Grant, award, or other acquisition
-
298 Added 0.44%
67,778 Common Stock
Nov 13 2023
SELL
Open market or private sale
$1,034 $10.66 p/Share
97 Reduced 0.14%
67,480 Common Stock
Nov 05 2023
BUY
Grant, award, or other acquisition
-
333 Added 0.49%
67,577 Common Stock
Oct 22 2023
BUY
Grant, award, or other acquisition
-
373 Added 0.55%
67,244 Common Stock
Oct 08 2023
BUY
Grant, award, or other acquisition
-
281 Added 0.42%
66,871 Common Stock
Sep 24 2023
BUY
Grant, award, or other acquisition
-
290 Added 0.43%
66,590 Common Stock
TW

Troy Wichterman

Chief Financial Officer
Bothell, WA

Track Institutional and Insider Activities on BLFS

Follow BIOLIFE SOLUTIONS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

News

Receive news related to BIOLIFE SOLUTIONS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BLFS